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ABSTRACT
During the past decade, extended-spectrum b-lactamase (ESBL)–producing Enterobacteriaceae have become a matter of
great concern in human medicine. ESBL-producing strains are found in the community, not just in hospital-associated patients,
which raises a question about possible reservoirs. Recent studies describe the occurrence of ESBL-producing Enterobacteriaceae
in meat, fish, and raw milk; therefore, the impact of food animals as reservoirs for and disseminators of such strains into the food
production chain must be assessed. In this pilot study, fecal samples of 59 pigs and 64 cattle were investigated to determine the
occurrence of ESBL-producing Enterobacteriaceae in farm animals at slaughter in Switzerland. Presumptive-positive colonies on
Brilliance ESBL agar were subjected to identification and antibiotic susceptibility testing including the disc diffusion method and
E-test ESBL strips. As many as 15.2% of the porcine and 17.1% of the bovine samples, predominantly from calves, yielded
ESBL producers. Of the 21 isolated strains, 20 were Escherichia coli, and one was Citrobacter youngae. PCR analysis revealed
that 18 strains including C. youngae produced CTX-M group 1 ESBLs, and three strains carried genes encoding for CTX-M
group 9 enzymes. In addition, eight isolates were PCR positive for TEM b-lactamase, but no blaSHV genes were detected. Pulsed-
field gel electrophoresis showed a high genetic diversity within the strains. The relatively high rates of occurrence of ESBL-
producing strains in food animals and the high genetic diversity among these strains indicate that there is an established reservoir
of these organisms in farm animals. Further studies are necessary to assess future trends.
Antimicrobial resistance in bacteria has emerged as a
problem in both human and veterinary medicine. Of current
interest is a resistance mechanism in Enterobacteriaceae
that reduces the efficacy even of modern expanded-
spectrum cephalosporins and monobactams; the mechanism
is based on plasmid-mediated production of enzymes that
inactivate these compounds by hydrolyzing their b-lactam
ring. These enzymes, called extended-spectrum b-lacta-
mases (ESBLs), are variants of well-known Ambler type A
serine b-lactamases. Around their active site, they have
undergone one to three amino acid exchanges that enable
them to extend their substrate spectrum to include oxyimino
cephalosporins and monobactams. While many ESBLs are
derivatives of classical broad-spectrum b-lactamases such as
TEM-1 or SHV-1, members of other families like CTX-M,
Oxa, PER, and KPC have recently been reported more
frequently (5). Moreover, resistance caused by ESBLs is
often associated with resistance to other classes of
antibiotics like fluoroquinolones, aminoglycosides, and
trimethoprim-sulfmethoxazole.
Since the first description of ESBL-producing Entero-
bacteriaceae isolated from hospitalized humans (14), many
nosocomial outbreaks have been reported. However, for
several years there has been an increase in the isolation of
ESBL-producing strains in the community (18). More
recently, various reports have discussed dissemination of
ESBL-producing Escherichia coli in healthy food-produc-
ing animals in several countries in Europe and Asia (6, 8,
10, 19, 23) or in food products like meat, fish, and raw milk
(11–13). Very recently Wittum et al. (24) and Doi et al. (7)
described ESBL producers in healthy dairy cattle and retail
meat in the United States.
Therefore, the impact of healthy farm animals as a
reservoir for ESBL-producing Enterobacteriaceae in the
food processing chain has to be assessed. The aim of the
present study was to screen for the occurrence of ESBL-
producing Enterobacteriaceae in swine and cattle at
slaughter and to further characterize isolated strains.
MATERIALS AND METHODS
Sampling. Fecal swab samples were collected in October
2009 from 123 animals: 59 pigs (57 fattening pigs and 2 piglets)
and 64 cattle (10 cows, 7 young cows, 38 calves, 3 bullocks, and 6
fattening bulls). Swabs of fecal matter were taken from animals at a
large slaughterhouse after cutting the large intestine with sterile
scissors after evisceration. Afterward the swabs were placed into
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sterile tubes, transported to the laboratory, and processed within 4 h
of collection. At most two animals per farm were sampled.
Microbiological analysis. Each swab was first suspended in
0.3 ml of 0.9% buffered peptone saline (BPS) and then incubated
for 24 h at 37uC in Enterobacteriaceae enrichment (EE) broth
(BD, Franklin Lakes, NJ). The BPS suspension and the enriched
fecal samples were inoculated onto Brilliance ESBL agar (Oxoid,
Hampshire, UK) and incubated at 37uC for 24 h under aerobic
conditions. All colonies were selected and subcultured onto triple
sugar iron agar (BD) at 37uC for 24 h. After performing the
oxidase test and assessing for lactose fermentation, nonfermenters
were discarded, and oxidase-negative colonies were subjected to
identification by API ID 32 E (bioMe´rieux, Marcy l’Etoile, France)
or by sequencing of 16S rRNA and rpoB genes (15, 20).
Antimicrobial susceptibility testing and ESBL detection.
All isolated strains were subjected to susceptibility testing against
14 antimicrobial agents by the disc diffusion method and evaluated
according to Clinical and Laboratory Standards Institute (3)
criteria. The antibiotics tested were amoxicillin–clavulanic acid,
cefpodoxime, cephalothin, cefepime, cefoxitin, cefotaxime (CTX),
cefuroxime, ceftazidime, ampicillin, ciprofloxacin, streptomycin,
gentamicin, chloramphenicol, and tetracycline (Becton Dickinson,
Heidelberg, Germany). The amoxicillin–clavulanic acid disc was
placed between the cefpodoxime and the ceftazidime discs, and the
synergy effect was documented. The strains that showed a synergy
effect were then confirmed as ESBL-producers on Mueller-Hinton
agar plates using E-test ESBL strips containing cefotaxime,
cefepime, or ceftazidime alone and in combination with clavulanic
acid (bioMe´rieux), respectively, according to the manufacturer’s
recommendations. This included reading the MICs from the strips
and calculating the ratio of (MIC cephalosporin)/(MIC cephalo-
sporin plus clavulanic acid).
Characterization of b-lactamases. Bacterial strains con-
firmed as ESBL producers were further analyzed by PCR. DNA
was extracted by a standard heat lysis protocol. Then five specific
primer sets were used to determine the presence of the blaTEM,
blaSHV, and blaCTX-M genes (21, 25).
Genotyping. Pulsed-field gel electrophoresis was performed
by following the CDC PulseNet protocol (http://www.cdc.gov/
pulsenet/protocols.htm) with minor modifications. Briefly, strains
were grown on blood agar at 37uC overnight. Colonies from blood
agar were resuspended in cell suspension buffer (optical density at
600 nm~ 1). The bacterial cell suspension was mixed with 400 ml
of 1.4% Bio-Rad Agarose (Bio-Rad, Munich, Germany), and cells
were lysed by proteinase K treatment overnight. After lysis the
plugs were washed twice for 15 min in ultrapure water and four
times for an hour in Tris-EDTA buffer. After washing with Tris-
EDTA buffer, DNA agarose plugs were incubated overnight in the
presence of XbaI (Roche, Mannheim, Germany) following the
manufacturer’s instructions. Restricted DNA in plug slices was
separated in a 1% SeaKem Gold (BioConcept, Allschwil,
Switzerland) agarose gel at 6 V/cm in 0.5| Tris-borate-EDTA
buffer cooled to 14uC in a CHEF-DR III system (Bio-Rad). The
pulse times were ramped from 5 to 50 s for 20 h at an angle of
120u. Gels were stained with ethidium bromide and visualized
under UV light transillumination using a Gel Doc system (Bio-
Rad) and analyzed with BioNumerics software (Applied Maths,
Sint-Martens-Latem, Belgium).
Salmonella Braenderup strain H9812 (ATCC BAA 664) was
used as a size standard.
RESULTS AND DISCUSSION
The 21 ESBL-producing strains were isolated from 20
animals (9 pigs, 1 cow, and 10 calves). All of the strains
showed a synergy effect with at least one of three E-test
ESBL strips containing cefepime, cefotaxime, or ceftazidime,
and they yielded factors .8 when MIC ratios were
calculated, such as (MIC cephalosporin)/(MIC cephalosporin
plus clavulanic acid). Identification of the isolates resulted in
20 cases in E. coli and one in Citrobacter youngae (Table 1).
Based on the MIC to oxyimino cephalosporins, four different
resistotypes could be described. Resistotypes 1, 1a, 2, and 3
were characterized by differing MICs to the three oxyimino
cephalosporins or by varying synergy effects (for more
details see footnotes in Table 1).
The b-lactamase genes of all ESBL-producing isolates
were further characterized by PCR. Seventeen (85%) of the
E. coli ESBL genes belonged to CTX-M group 1, and three
(15%; one porcine, two bovine samples) belonged to CTX-M
group 9. TheC. youngae isolate belonged to CTX-M group 1.
None of the 21 ESBL producers harbored blaSHV, but all of
the CTX-M group 9–positive isolates and 29.4% of the
CTX-M group 1–positive E. coli also harbored blaTEM. The
C. youngae isolate was negative for both blaTEM and blaSHV.
In addition to these b-lactam resistances, we also tested for
other classes of antibiotics; we found 15 strains resistant to
tetracycline, 15 strains resistant to streptomycin, 10 strains
resistant to chloramphenicol, 9 strains resistant to gentamicin,
and 9 strains resistant to ciprofloxacin (Table 1).
There have only been a few studies describing the
prevalence and characteristics of ESBL-producing En-
terobacteriaceae in healthy farm animals. Very low
prevalences were described for pigs in Denmark and
cattle in France (17, 26). No prevalence data were
available for Switzerland and other European countries.
The predominance of CTX-M group 1 enzymes, as seen
in our study, has also recently been described in strains
from healthy food-producing animals in Denmark,
Portugal, and France (1, 9, 10). In our study, 15% of
the E. coli isolates belonged to CTX-M group 9. Notably,
almost 30% of the ESBL-producing strains in the present
study contained an additional blaTEM gene. TEM
producers are often isolated from poultry (22) but rarely
from other animals (2, 4, 16). Although the blaTEM genes
were not further characterized, they can be expected to
belong to the classical group of broad-spectrum b-
lactamases conveying no ESBL phenotype.
The ESBL-producing strains showed high genetic
diversity by pulsed-field gel electrophoresis analysis
(Fig. 1). This is a matter of concern, since it shows that
no single clone has spread within the animal population.
Instead, propagation of resistance among E. coli populations
in animals occurs more probably by plasmids harboring
blaESBL genes.
The presence of ESBL-producing Enterobacteriaceae
in fecal samples of farm animals represents a risk for carcass
contamination at slaughter and therefore also indicates the
potential for contamination of retail meat products. This, in
turn, may lead to colonization of healthy humans with
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ESBL-producing bacteria and thus may jeopardize subse-
quent antimicrobial therapies on carriers. Therefore, further
efforts within the field of veterinary public health are of
major importance. It is recommended that a monitoring
system be established to analyze further trends of ESBL
frequencies, in order to prevent further corruption of the
efficacy of the important oxyimino cephalosporins in the
treatment of severe human infections.
FIGURE 1. Pulsed-field gel electrophoresis dendrogram (Dice similarity index and unweighted pair group method with arithmetic mean)
of the 20 ESBL-producing E. coli isolated from fecal samples of pigs and cattle at slaughter.
TABLE 1. Identification and characterization of the 21 ESBL producers isolated from fecal samples of 59 pigs and 64 cattle at slaughter
Sample no. Animal Identificationa Resistotypeb
CTX-M
group 1
CTX-M
group 2
CTX-M
group 9 blaSHV blaTEM
Other antibiotic
resistancesc
13 Pig E. coli 1 zd 2e 2 2 2 S, TE
14 Pig E. coli 1 z 2 2 2 2 TE
16 Pig E. coli 1a 2 2 z 2 z S, C, TE, GM, CIP
17 Pig E. coli 1a z 2 2 2 z S, TE, CIP
18 Pig E. coli 1 z 2 2 2 z S, C, TE, CIP
46 Calf E. coli 2 z 2 2 2 2 S, C, TE, GM
47 Calf E. coli 2 z 2 2 2 2 S, C, TE, GM
52 Calf E. coli 3 z 2 2 2 2 TE, GM, CIP
53 Cow E. coli 3 z 2 2 2 2 CIP
60 Pig E. coli 1 z 2 2 2 z S
64 Pig E. coli 2 z 2 2 2 2 —
65 Pig E. coli 2 z 2 2 2 2 TE
72 Pig E. coli 1a z 2 2 2 z S
112 Calf E. coli 2 z 2 2 2 2 S, C, TE, GM
114 Calf E. coli 2 z 2 2 2 2 S, C, TE, GM, CIP
115 Calf E. coli 1a 2 2 z 2 z C, CIP
116 Calf E. coli 1a 2 2 z 2 z S, C, TE, GM, CIP
124 Calf E. coli 3 z 2 2 2 2 S, CIP
129 Calf E. coli 2 z 2 2 2 z S, TE
142a Calf E. coli 2 z 2 2 2 2 S, C, TE, GM
142b Calf C. youngae 2 z 2 2 2 2 S, C, TE, GM
a E. coli identification by API ID 32; C. youngae identification by sequencing of 16S rRNA and rpoB genes.
b Resistotype 1 (1 , MIC cefepime # 8, synergy effect; MIC cefotaxime . 16, synergy effect; 0.5 # MIC ceftazidime # 1, synergy
effect); resistotype 1a (like resistotype 1, but without synergy effect with strip cefotaxime/cefotaxime plus clavulanic acid); resistotype 2
(0.5#MIC cefepime# 1, MIC cefotaxime$ 4, MIC ceftazidime# 0.5); resistotype 3 (MIC cefepime$ 3, MIC cefotaxime. 16, MIC
ceftazidime $ 4).
c S, streptomycin; TE, tetracycline; C, chloramphenicol; GM, gentamicin; CIP, ciprofloxacin.
d z, present.
e 2, absent.
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